A similar downregulation of ESR1 protein level by miR-221 and -222 was observed in T47D luminal A type breast cancer cells, whereas ESR1 expression is undetectable in the HER2+ subtype SKBr-3 cells (Fig. 3E,F). The gene discussed is ERBB2; the disease is breast carcinoma.